Cvijetić, IN;
Verbić, TZ;
de Resende, PE;
Stapleton, P;
Gibbons, S;
Juranić, IO;
Drakulić, BJ;
(2018)
Design, synthesis and biological evaluation of novel aryldiketo acids with enhanced antibacterial activity against multidrug resistant bacterial strains.
European Journal of Medicinal Chemistry
, 143
pp. 1474-1488.
10.1016/j.ejmech.2017.10.045.
Preview |
Text (Accepted manuscript)
Cvijetic_Design_synthesis_biological_evaluation_revision_final.pdf - Accepted Version Download (1MB) | Preview |
Preview |
Text (Supplementary figures)
Cvijetic_Design_synthesis_biological_evaluation_final.pdf - Accepted Version Download (4MB) | Preview |
Preview |
Text (Graphical abstract)
Cvijetic_Design_synthesis_biological_evaluation_Graph_abstract.pdf - Accepted Version Download (313kB) | Preview |
Abstract
Antimicrobial resistance (AMR) is a major health problem worldwide, because of ability of bacteria, fungi and viruses to evade known therapeutic agents used in treatment of infections. Aryldiketo acids (ADK) have shown antimicrobial activity against several resistant strains including Gram-positive Staphylococcus Aureus bacteria. Our previous studies revealed that ADK analogues having bulky alkyl group in ortho position on a phenyl ring have up to ten times better activity than norfloxacin against the same strains. Rational modifications of analogues by introduction of hydrophobic substituents on the aromatic ring has led to more than tenfold increase in antibacterial activity against multidrug resistant Gram positive strains. To elucidate a potential mechanism of action for this potentially novel class of antimicrobials, several bacterial enzymes were identified as putative targets according to literature data and pharmacophoric similarity searches for potent ADK analogues. Among the seven bacterial targets chosen, the strongest favorable binding interactions were observed between most active analogue and S. aureus dehydrosqualene synthase and DNA gyrase. Furthermore, the docking results in combination with literature data suggest that these novel molecules could also target several other bacterial enzymes, including prenyl-transferases and methionine aminopeptidase. These results and our statistically significant 3D QSAR model could be used to guide the further design of more potent derivatives as well as in virtual screening for novel antibacterial agents.
| Type: | Article |
|---|---|
| Title: | Design, synthesis and biological evaluation of novel aryldiketo acids with enhanced antibacterial activity against multidrug resistant bacterial strains |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ejmech.2017.10.045 |
| Publisher version: | https://doi.org/10.1016/j.ejmech.2017.10.045 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | aryl diketo acid, antimicrobial activity, multidrug resistance, Gram-positive, 3D QSAR, molecular docking, dehydrosqualene synthase |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharma and Bio Chemistry |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10025064 |
Archive Staff Only
 |
View Item |
